EP4223296
NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS
Zusammenfassung
The present invention relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who has a high drinking risk level. The present invention also relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who maintains a high DRL after an observation period following initial assessment.
Anmelder
H LUNDBECK AS [DK]
Erfinder
TORUP LARS [DK]ABBARIKI AFSANEH [DK]BLADSTRÖM ANNA [SE]PERSSON CHRISTINE [SE]MEULIEN DIDIER [FR]SØRENSEN PER [DK]JENSEN THOMAS JON [DK]ØSTERGAARD JETTE BUCH [DK]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 31/485A61P 25/32
CPC-Klassen
A61K 31/485A61K 9/0053A61K 9/20A61K 9/48A61P 25/00A61P 25/32A61P 43/00
AI: Life Sciences
warum
Same compound and indication as EP3345604 — Lundbeck pharma. Life Science.